InflaRx Announces Public Offering of Ordinary Shares and Pre-Funded Warrants
InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting ...
Why Okta, Inc. (OKTA) Is Skyrocketing So Far in 2025?
We recently published a list of Why These 15 Large Tech Stocks Are Skyrocketing So Far in 2025. In this article, we are going ...